395 W 12th Ave
Columbus, OH 43210
Phone: (614) 293-4997
Assistant Professor-Clinical, Nephrology
I do not have any noteworthy accomplishments in the undergraduate student teaching
I believe that I have noteworthy achievements in the areas of education, scholarship and service that qualify me to apply for promotion to the Associate Professor level. My main focus has always been excellence in patient care which I believe is central to being a physician. My very good patient satisfaction ratings and clinical volume reflect my diligent work ethic.
Teaching is my passion and I spend substantial amounts of time in doing bedside teaching both during inpatient rounds and in the clinic. My superior evaluations from house-staff and by my division chief during annual reviews stand testimony to my efforts in this area.
I continue to participate in the citizenship activities at the division, medical center and the College levels in key areas. Examples are the cancer IRB and the College of Medicine admissions screening committee.
Despite being very active as a full time clinician, I took time to be active in clinical research and produced several scholarly articles in mainstream journals. I am currently writing 4 manuscripts for publication – studies that were presented at the national meetings in 2012 and 2013. I presented my clinical research at national and international conferences on a regular basis, including six abstracts this year at the World Transplant Congress.
I also initiated some basic research activities recently and made good progress in collaboration with investigators from the Department of Physiology and Cell Biology. We are in the process of applying for a substantial funding opportunity from CCTS.
I serve on the board of directors and the medical advisory board for the regional National Kidney Foundation.
I was named to the Best Doctors® list last year which recognizes only about 5% of all practicing physicians in the US.
Overall, I feel that my current accomplishments in the regional and at national level are sufficient to allow my promotion to the Associate Professor level. I hope that my record is viewed favorably by the promotion and tenure committee.
I received "Excellence in Teaching" award by the students of the Independent Study Pathway (ISP) program for the year 2011-12. This award is given to one module leader each year after all the ISP modules are administered. It is based on the quality of teaching, content of the module and the academic support given by the module leader. Award included a plaque and a token gift card.
|2012 - present||Sarah Adelson The Ohio State University.|
|2013 - present||Chad Liber The Ohio State University.|
|2012||Andrew Para The Ohio State University.|
|2012||Clayton Wisely The Ohio State University.|
|2012 - 2013||Gregory Jungwirth The Ohio State University.|
Nori US. "Impact of Recurrent Autoimmune Diseases in Renal Transplant Outcomes." In Encyclopedia of Medical Immunology. Edited by Dr. Brad Rovin. -.
Nori US, Agarwal AK. "Evaluation of Patients with Kidney Disease." In Textbook of Nephrology for Asian-Pacific Physicians 2nd edition. Edited by Anil Mandal, MD. -.
|2005 - present||International Journal of Nephrology|
|2005 - present||Nephrology Dialysis Transplantation|
|2005 - present||Annals of Internal Medicine|
|2005 - present||Pediatric Nephrology|
|2005 - present||American Journal of Hematology|
|2005 - present||Seminars in Dialysis|
|2006 - present||Kidney International|
|2008 - present||American Journal of Kidney Diseases|
|2009 - present||Clinical Nephrology|
|2011||Fellow of National Kidney Foundation. National Kidney Foundation.|
|2012 - present||Best Doctors. Columbus Monthly.|
|2013 - present||Champion of the Year. National Kidney Foundation.|
|2013 - present||Best Doctors. Best Doctors Inc.|
Ravinuthala RS; Nori U. "Rosiglitazone toxicity.." Annals Of Internal Medicine. Vol. 133, no. 8. (October 2000.): 658-.
Attallah N; Goggins M; Nori U; Abouljoud M; Zasuwa G; Venkat KK; Parasuraman R. "Comparison of long-term actual renal allograft survival in mycophenolate mofetil and azathioprine-based triple drug immunosuppression protocols.." Transplantation Proceedings. Vol. 37, no. 5. (June 2005.): 2060-.
Hebert LA; Nori U; Hebert PL. "Measured and estimated glomerular filtration rate.." The New England Journal Of Medicine. Vol. 355, no. 10. (September 2006.): 1068; author reply 1069-70.
Singh N; Nori U; Pesavento T. "Kidney transplantation in the elderly.." Current Opinion In Organ Transplantation. Vol. 14, no. 4. (August 2009.): 380-.
Nori US, Agarwal AK, Von Visger JR. "Dietary therapy in hypertension." New England Journal of Medicine. Vol. 363, no. 16. (October 2010.): 1582-1583.
Simon MR, Jan M, Yee J, Nori US, Hu J, Akin C, Schwartz LB. "Tryptase is not cleared by the kidneys into the urine." International Archives of Allergy and Immunology. Vol. 152, no. 1. (April 2010.): 28-31.
Hebert PL, Nori US, Bhatt UY, Hebert LA. "A modest proposal for improving the accuracy of creatinine-based GFR estimating equations." Nephrology Dialysis Transplantation. Vol. 26, no. 8. (March 2011.): 2426-8.
Nori US, Pesavento TE, Hebert LA.. "Measured GFR has limited clinical utility." American Journal of Kidney Diseases. Vol. 57, no. 1. (January 2011.): 180-181.
Singh,Neeraj; Parikh,Samir; Bhatt,Udayan; VonVisger,Jon; Nori,Uday; Hasan,Ayesha; Samavedi,Srinivas; Andreoni,Kenneth; Henry,Mitchell; Pelletier,Ronald; Rajab,Amer; Elkhammas,Elmahdi; Pesavento,Todd. "Cardiac Stress Test as a Risk-Stratification Tool for Posttransplant Cardiac Outcomes in Diabetic Kidney Transplant Recipients." TRANSPLANTATION. Vol. 94, no. 12. (December 2012.): 1224-1229.
Parikh,Samir; Nagaraja,Haikady; Agarwal,Anil; Samavedi,Srinivas; Von Visger,Jon; Nori,Uday; Andreoni,Kenneth; Pesavento,Todd; Singh,Neeraj. "Impact of post-kidney transplant parathyroidectomy on allograft function." CLINICAL TRANSPLANTATION. Vol. 27, no. 3. (May 2013.): 397-402.
Oghumu S, Bracewell A, Nori U, MacLean KH, Balada-Lasat JM, Brodsky S, Pelletier R, Henry M, Satoskar AR, Nadasdy T, Satoskar AA. "Acute Pyelonephritis in Renal Allografts - A New Role for MicroRNAs?." Transplantation. Vol. 97, no. 5. (March 2014.): 559-68.
|October 2004||Nori US, Manoharan A, Fisher KA, Osman Y, Besarab A."Use of Antibiotic Lock Therapy in Prevention of Hemodialysis Catheter Related Bacteremia" St. Louis, MO.|
|November 2004||Nori US, Abrego P, Frinak S, Yee J, Dunfee T, Goggins M."Efficiency of Hemodialysis for Removal of Uric Acid in Patients with Severe Tophaceous Gouty Arthritis Using High Flux Membranes" San Diego, CA.|
|October 2004||Nori US, Parasuraman R, Ramanathan V."Incidence and epidemiology of infective endocarditis in patients receiving long-term hemodialysis" St. Louis.|
|May 2005||Deel C, Nori US, Pescovitz M, Govani MV."Erratic pharmacokinetics of Neoral® in stable renal transplant recipients with type 1 diabetes" Seattle, WA.|
|November 2005||Govani MV, Nori US, Mishler D."Excellent Graft Survival in Renal Transplant Recipients with BK Virus Nephropathy" Philadelphia, PA.|
|July 2006||Pesavento TE, Davies EA, Von Visger JV, Nori U, Miller BS, Ferguson RM."Randomized, prospective withdrawal trial in kidney transplant patients treated with mycophenolate sodium comparing rapamycin vs. C2 dosed cyclosporine" Boston. : 300|
|July 2006||Sharfuddin AA, Yaqub MS, Mishler DP, Milgrom ML, Goggins WC, Nori US, Govani MV."Steroid sparing is not associated with lower GFR in renal transplant recipients" Boston, MA.|
|May 2007||Von Visger J, Pesavento TE, Nori US, Elkhammas, E."Prolonged early graft dysfunction with sirolimusand association with mortality in renal transplant recipients." Boston. : 533|
|May 2007||Von Visger J, Pesavento TE, Nori US."Increased Mortality Risk for Renal transplant recipients on sirolimusand delayed graft function: A review of 74,000 patients" Boston. : 163|
|May 2007||Pesavento TE, Nori U, Von Visger J, Henry ML, Ferguson RM."Sirolimus, independent of cyclosporine, is associatedwith worsened proteinuria in renal transplantation" Boston. : 264|
|May 2008||Nori US, Pesavento TE, Davies EA, Von Visger J, Miller BS, Ferguson RM."Randomized, prospective prednisone withdrawal trial in kidney transplant patients treated with sirolimus vs. microemulsified cyclosporine based regimens" Boston. : 301|
|May 2009||Pesavento TE, Nori US, Satoskar A, Dils D, Henry ML, Von Visger J, Singh N."Use of baseline kidney biopsies and pulsatile perfusion parameters to predict graft outcome in deceased donor kidney transplants" Boston. : 313|
|May 2009||Pesavento TE, Winoto J, Nori US, Von Visger J, Singh N."Risk of recurrent focal segmental glomerulosclerosis in patients following loss of native kidneys and primary transplantfrom recurrent FSGS. Is retransplantation prudent?" Boston. : 685|
|April 2010||Singh N, Gunay Y, Samavedi S, Parikh S, Von Visger J, Nori US, Pesavento TE, Henry ML, Elkhammas E."Recurrence of IgA nephropathy post kidney transplantation in steroid free vs. steroid dependent immunosuppression protocol" Boston. : 519|
|April 2010||Parikh S, Gunay Y, Samavedi S, Shah R, Von Visger J, Nori US, Rajab A, Pesavento TE, Singh N."Cardiac stress test as a risk stratification tool for early postKidney transplant cardiovascular outcomes in diabetic ESRD patients" Boston. : 306|
|May 2012||Nori US, Von Visger J, Shah R, Haddad N, Agarwal AK."Management of Renal Transplant Recipients with Failing Allografts and Transitioning to Renal Replacement Therapy" Boston.|
|May 2013||Von Visger J, Pesavento TE, Pelletier RP, Diez A, Nori US."Tolerance of ACE-Inhibitor/ARB Use Post Renal Transplant" Malden, MA. : 355|
|June 2013||Nori US, Pesavento C, Diez A, Von Visger J."RISK FACTORS AND PREDICTABILITY OF REQUIRING TRANSPLANT NEPHRECTOMY AFTER LATE ALLOGRAFT FAILURE" Hong Kong.|
|Woodle ES, Marder B, Harler MB, Vincenti F, Citterio F, Nori US, Grinyó J."Renal Function at 4 Years in a Phase 2 Randomized Trial Evaluating Belatacept-Based Regimens With Simultaneous Calcineurin Inhibitor and Corticosteroid Avoidance in Kidney Transplant Recipients" .|
|Von Visger J, Pargeter K, Diez A, Pesavento TE, Pelletier RP, Henry M, Elkhammas EA, Nori US."Impact of Early Graft Dysfunction" .|
|El-Hinnawi A, Elkhammas EA, Pelletier RP, Rajab A, Nori US, Von Visger J, Bumgardner G, Davies EA, Black S, Zaaroura A, Henry M."Pediatric Donors for Simultaneous Pancreas-Kidney Transplant" .|
|Grinyó J, Marder B, Harler MB, Vincenti F, Citterio F, Nori US, Woodle ES."Outcomes at 4 years in a Phase 2 Randomized Trial Evaluating Belatacept-Based Regimens With Simultaneous Calcineurin Inhibitor and Steroid-Avoidance in Kidney Transplant Recipients" .|
|Diez A, Von Visger J, Nori US, Pelletier RP, Henry M, Pesavento TE."Donor-Specific Transfusions Vs. Cyclosporine in Living Donor Kidney Transplantation: 30 Year Outcomes" .|
"Drug Prescribing in Chronic Kidney Disease." Presented at National Kidney Foundation Annual Meeting - Ohio Chapter, Columbus, OH, US|USA. (May 2008)
"Cardiovascular Disease in CKD Optimizing Screening Strategies." Presented at National Kidney Foundation - Ohio, Kentucky chapter, Columbus, Ohio. (May 2009)
"Cardiovascular Testing in Patients Undergoing Kidney Transplantation." Presented at National Kidney Foundation Annual Meeting - Ohio Chapter, Columbus, OH, US|USA. (January 2009)
"Pitfalls in the estimation of GFR." Presented at Update in Internal Medicine, State College, PA, Pennsylvania. (October 2012)
"Kidney Transplantation as the Treatment of Choice in Chronic Kidney Disease." Presented at National Kidney Foundation - Ohio, Kentucky, Tennessee chapter, Columbus, Ohio. (May 2012)
"Save the Transplant Nephron: Thinking Out of the Box." Presented at Kim Thomas Memorial Annual Transplant Symposium, Greenville, NC, North Carolina. (October 2013)
"Increasing Living Donor Kidney Transplantation." Presented at National Kidney Foundation - Ohio, Kentucky, Tennessee Chapter, Columbus, Ohio. (May 2013)
Von Visger J, Gunay Y, Andreoni KA, Bhatt U, Nori US, Pesavento TE, Elkhammas EA, Winters H, Nadasdy T, Singh N. The Risk of Recurrent IgA Nephropathy in a Steroid-free Protocol and other Modifying Immunosuppression. July 2013.